ArticleFrontiers in endocrinology2026

Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study.

Martina Galasso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.